EXAGEN INC (XGN)
US30068X1037 - Common Stock
These stocks are moving in today's session
Wondering how the US markets performed one hour before the close of the markets on Thursday? Discover the movers and shakers of today's session in our comprehensive analysis.
Exagen Inc. Achieves Key Milestone with 1,000,000th Patient Tested by AVISE® CTD
The milestone demonstrates AVISE CTD’s value and adoption within the rheumatologic community, clearly demonstrating superior laboratory testing for improved patient care
Exagen Inc. Achieves Key Milestone with 1,000,000th Patient Tested by AVISE® CTD
The milestone demonstrates AVISE CTD’s value and adoption within the rheumatologic community, clearly demonstrating superior laboratory testing for...
Exagen Inc. Completes Validation and Regulatory Submission for New Lupus and Rheumatoid Arthritis Biomarkers on the AVISE® CTD Platform
Significant enhancements will equip clinicians with even more diagnostic clarity in the treatment of patients with autoimmune disease
Exagen Inc. Completes Validation and Regulatory Submission for New Lupus and Rheumatoid Arthritis Biomarkers on the AVISE® CTD Platform
Significant enhancements will equip clinicians with even more diagnostic clarity in the treatment of patients with autoimmune disease...
Exagen Inc. to Participate in Fourth Quarter Investor Conferences
Exagen Inc. Reports Third Quarter 2024 Results
Exagen Inc. Reports Third Quarter 2024 Results
Expanded AVISE® CTD trailing twelve-month average selling priceReduced Adjusted EBITDA loss for first three quarters of 2024Revenue in line with...
Exagen to Announce Third Quarter 2024 Results on November 12, 2024
Exagen to Announce Third Quarter 2024 Results on November 12, 2024
CARLSBAD, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, will release financial results...
Exagen Announces Acceptance of Five Abstracts at 2024 American College of Rheumatology Convergence
Exagen Announces Acceptance of Five Abstracts at 2024 American College of Rheumatology Convergence
CARLSBAD, Calif., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, announced today the acceptance...
Exagen Inc. to Participate in the 2024 Cantor Global Healthcare Conference
Exagen Inc. to Participate in the 2024 Cantor Global Healthcare Conference
CARLSBAD, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its...
Wednesday Sector Laggards: Advertising, Diagnostics
Market Mayhem Winners: What Stocks Are Up Today?
What stocks are up today? It’s a natural question following the implosion of the global markets and the answer might surprise you.
XGN Stock Earnings: Exagen Beats EPS, Beats Revenue for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Exagen (NASDAQ:XGN) just reported results for the second quarter of 2024.Exagen...
XGN Stock Earnings: Exagen Beats EPS, Beats Revenue for Q2 2024
XGN stock results show that Exagen beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Exagen Inc. Reports Strong Second Quarter 2024 Results: Raises Guidance due to Record Performance
Exagen Inc. Reports Strong Second Quarter 2024 Results: Raises Guidance due to Record Performance
CARLSBAD, Calif., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported...
Exagen Inc. to Participate in the Canaccord Genuity 44th Annual Growth Conference
Exagen Inc. to Participate in the Canaccord Genuity 44th Annual Growth Conference
CARLSBAD, Calif., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its...
Exagen Appoints Jeffrey G. Black as New Chief Financial Officer
Exagen Appoints Jeffrey G. Black as New Chief Financial Officer
CARLSBAD, Calif., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions announced today the...
Exagen to Announce Second Quarter 2024 Results on August 5, 2024
Exagen to Announce Second Quarter 2024 Results on August 5, 2024
CARLSBAD, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, will release financial results...
XGN Stock Earnings: Exagen Beats EPS, Beats Revenue for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Exagen (NASDAQ:XGN) just reported results for the first quarter of 2024.Exagen ...
XGN Stock Earnings: Exagen Beats EPS, Beats Revenue for Q1 2024
XGN stock results show that Exagen beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full Year
Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full Year
CARLSBAD, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported...
Exagen Announces Campaign for Lupus Awareness Month
Exagen to Announce First Quarter 2024 Results on May 13, 2024
Exagen to Announce First Quarter 2024 Results on May 13, 2024
CARLSBAD, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, will release financial results...
Exagen Inc. Announces Changes to the Board of Directors
Exagen Inc. Announces Changes to the Board of Directors
CARLSBAD, Calif., April 26, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced...
XGN Stock Earnings: Exagen Beats EPS, Beats Revenue for Q4 2023
XGN stock results show that Exagen beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results
CARLSBAD, Calif., March 18, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported...